• Skip to primary navigation
  • Skip to main content
  • 786-300-3183
  • executiveoffice@fsahq.org
  • Facebook
  • Twitter
Florida Society of Anesthesiologists

Florida Society of Anesthesiologists

  • About FSA
    • FSA Leadership
    • Contact FSA
    • FSA Charter & Bylaws
    • FSA Speakers Bureau
    • Practice Management
  • Annual Meeting
    • Call For Abstracts
    • Meeting Info
    • Past Posters
      • 2020 FSA Posters
      • 2019 FSA Posters
      • 2018 FSA Posters
      • 2017 FSA Posters
      • 2016 FSA Posters
    • Past Meetings
      • 2019 Annual Meeting Recap
      • 2018 Annual Meeting Recap
      • 2017 Annual Meeting Recap
      • 2016 Annual Meeting Recap
      • 2014 Annual Meeting Recap
    • Calendar of Events
  • FSAPAC
    • Donate to FSAPAC
    • FSAPAC 2020 Donor Honor Roll
    • FSAPAC 2019 Donor Honor Roll
    • FSAPAC 2018 Donor Honor Roll
    • FSAPAC 2017 Donor Honor Roll
    • FSAPAC 2016 Donor Honor Roll
    • FSAPAC 2015 Donor Honor Roll
    • FSAPAC 2014 Donor Honor Roll
    • FSAPAC 2013 Donor Honor Roll
  • FSA Newsletter
  • Legislation News
  • Membership Renewal
  • Join the Florida Society of Anesthesiologists (FSA)
  • Member Resources
  • Minutes Matter Most

2016 FSA Posters

P042: DELAYED EMERGENCE AND DIBUCAINE NUMBER
Joann Bolton, Grace Cruz, E Rodrigues; Mayo Clinic Florida

Introduction/Background: A 63-year-old man with a history of delayed emergence following an upper enteroscopy presented for laparoscopic small bowel resection following diagnosis of a small bleeding mass requiring blood transfusions. Following his enteroscopy a month prior, he was extubated and transported to the recovery room. He was on a BIPAP for several hours due to hypercarbia. After several hours, he was discharged home.

Due to his history of slow emergence, midazolam was avoided prior to induction of anesthesia. Rapid sequence intubation using succinylcholine was performed due to active bleeding. His airway was secured and surgical procedure began. Throughout his procedure, it was observed that his train of four stimulation did not illicit a twitch response beyond 0/4. Because of this, he was kept intubated and sedated during transport to the recovery room and until he had full recovery of train of four 5 hours after administration of succinylcholine. At this time, he was extubated and monitored prior to transportation to the surgical floor.

Results: To verify this patient’s suspected slow metabolism of succinylcholine, a dibucaine number and pseudocholinesterase level was drawn. His dibucaine number was within normal ranges at 82, however his pseudocholinesterase level was 1252, where normal low is 3100. The patient was contacted about this finding and his wife informed us that his sister had a similar issue with anesthesia. They were advised that this deficiency is genetic and other family members may be at risk of having a prolonged effect from succinylcholine.

Discussion/Conclusion: This patient presented with prior history of respiratory failure following anesthesia suspicious for pseudocholinesterase deficiency. Classically, it is taught that a dibucaine level greater than 80 is homozygous normal, a level of 30-70 indicates a heterozygous atypical, and levels below 30 are homozygous atypical. Our patient presents with a normal range dibucaine number which demonstrates the importance of measuring the pseudocholinesterase levels when suspecting issues with metabolizing succinylcholine. 

Copyright © 2021 Florida Society of Anesthesiologists ยท Managed by BSC Management, Inc.